RecruitingNCT07389473

Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device


Sponsor

Gaize

Enrollment

50 participants

Start Date

Apr 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is using a device called Gaize — a headset that tracks eye movements — to see how long-term use of psychiatric medications affects how the eyes and brain work together. Changes in eye movement patterns can sometimes reflect changes in how the brain processes information. **You may be eligible if...** - You are between 18 and 65 years old - You have been taking a prescribed psychiatric medication for more than 3 months - You have normal vision or corrected vision (glasses, contacts, or prior eye surgery) - You have given written informed consent **You may NOT be eligible if...** - You are currently enrolled in or participated in another clinical trial within the last 30 days - You have a prosthetic or missing eye, or wear an eye patch - You had LASIK or other eye surgery within the last 21 days - Your eyes were dilated by a doctor in the last 24 hours - You have photosensitive epilepsy - You have glaucoma, macular degeneration, cataracts, amblyopia (lazy eye), or optic neuritis - You have a history of traumatic brain injury - You are pregnant - You have a history of severe motion sickness in virtual reality environments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPrescription Psychotropic Medications

Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.


Locations(1)

Gaize

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07389473


Related Trials